Makay Özer, Özdemir Murat, Şenyürek Yasemin Giles, Tunca Fatih, Düren Mete, Uludağ Mehmet, Hacıyanlı Mehmet, Içöz Gökhan, Işgör Adnan, Özbaş Serdar, Özcan Zehra, Tezelman Serdar
Departments of General Surgey (Ö.M., M.Ö.
Turk J Surg. 2018 Jul 1;34(2):89-93. doi: 10.5152/turkjsurg.2018.3596. eCollection 2018.
The incidence of papillary microcarcinomas, which are defined as thyroid cancers of <10mm in size, has been increasing in the last decade. Herein, we present internet-based questionnaire results performed by the Turkish Association of Endocrine Surgery with the aim to evaluate the perspective of the management of papillary microcarcinomas in Turkey.
The user-friendly questionnaire consisted of 13 questions in total. These questions mainly addressed the surgical management of nodules and cancer of <1 cm in size. Patient management before, during, and after surgical intervention was also included; additionally, the "active surveillance approach" was questioned.
There were 420 responders in total who were of multidisciplinary origin (endocrinologists, surgeons, nuclear medicine specialists, pathologists, and oncologists). Total thyroidectomy was the predominant treatment approach (65%) for the classical type of microcarcinoma limited in one lobe, whereas in cases of microcarcinomas incidentally diagnosed during hemithyroidectomy, complementary surgery approach was advised by 40% of the responders. The responders found capsule invasion (86%) and patient based management (94%) of high importance. The percentage of the responders who recommended radioactive iodine ablation in incidental cancers having no aggressive criteria was 51%. The survey participants that were against routine central dissection in these cases accounted for 73% of the responders. The recommendation of active surveillance (follow-up without any interventional therapy) was limited with 9% responders.
The results of the questionnaire demonstrated that there have been various choices in Turkey for the surgical treatment of the papillary microcarcinomas.
乳头状微小癌定义为大小小于10毫米的甲状腺癌，其发病率在过去十年中呈上升趋势。在此，我们展示了土耳其内分泌外科学会通过网络问卷得出的结果，旨在评估土耳其对乳头状微小癌的治疗观点。
这份用户友好型问卷总共包含13个问题。这些问题主要涉及大小小于1厘米的结节和癌症的手术治疗。还包括手术干预前、手术过程中和手术后的患者管理；此外，还对“主动监测方法”进行了询问。
总共有420名来自多学科领域（内分泌学家、外科医生、核医学专家、病理学家和肿瘤学家）的受访者。对于局限于一叶的经典型微小癌，甲状腺全切术是主要的治疗方法（65%），而对于在半甲状腺切除术中偶然诊断出的微小癌病例，40%的受访者建议采用补充手术方法。受访者认为包膜侵犯（86%）和基于患者的管理（94%）非常重要。对于无侵袭性标准的偶然癌，建议进行放射性碘消融的受访者比例为51%。在这些病例中反对常规中央区清扫的调查参与者占受访者的73%。建议进行主动监测（不进行任何介入治疗的随访）的受访者仅占9%。
问卷结果表明，在土耳其，乳头状微小癌的手术治疗有多种选择。
